Efficacy of screening mammography. A meta-analysis.

OBJECTIVE To determine the efficacy of screening mammography by age, number of mammographic views per screen, screening interval, and duration of follow-up. DESIGN Literature review and meta-analysis. DATA IDENTIFICATION AND ANALYSIS: Literature search of English-language studies reported from January 1966 to October 31, 1993, using MEDLINE, manual literature review, and consultation with experts. A total of 13 studies were selected, and their results were combined using meta-analytic techniques based on the assumption of fixed effects. MAIN RESULTS The overall summary relative risk (RR) estimate for breast cancer mortality for women aged 50 to 74 years undergoing screening mammography compared with those who did not was 0.74 (95% confidence interval [CI], 0.66 to 0.83). The magnitude of the benefit in this age group was similar regardless of number of mammographic views per screen, screening interval, or duration of follow-up. In contrast, none of the summary RR estimates for women aged 40 to 49 years was significantly less than 1.0, irrespective of screening intervention or duration of follow-up. The overall summary RR estimate in women aged 40 to 49 years was 0.93 (95% CI, 0.76 to 1.13); the summary RR estimate for those studies that used two-view mammography was 0.87 (95% CI, 0.68 to 1.12) compared with 1.02 (95% CI, 0.73 to 1.44) for those studies that used one-view mammography, and for those studies with 7 to 9 years of follow-up, the summary RR estimate was 1.02 (95% CI, 0.82 to 1.27) compared with 0.83 (95% CI, 0.65 to 1.06) for those studies with 10 to 12 years of follow-up. CONCLUSION Screening mammography significantly reduces breast cancer mortality in women aged 50 to 74 years after 7 to 9 years of follow-up, regardless of screening interval or number of mammographic views per screen. There is no reduction in breast cancer mortality in women aged 40 to 49 years after 7 to 9 years of follow-up. Screening mammography may be effective in reducing breast cancer mortality in women aged 40 to 49 years after 10 to 12 years of follow-up, but the same benefit could probably be achieved by beginning screening at menopause or 50 years of age.

[1]  Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness. , 1994, Journal of the National Cancer Institute.

[2]  S Shapiro,et al.  Report of the International Workshop on Screening for Breast Cancer. , 1993, Journal of the National Cancer Institute.

[3]  E A Sickles,et al.  Baseline screening mammography: one vs two views per breast. , 1986, AJR. American journal of roentgenology.

[4]  R. Brookmeyer,et al.  Factors influencing the age at natural menopause. , 1987, Journal of chronic diseases.

[5]  L. Baker,et al.  Breast cancer detection demonstration project: Five‐year summary report , 1982, CA: a cancer journal for clinicians.

[6]  S Greenland,et al.  Quantitative methods in the review of epidemiologic literature. , 1987, Epidemiologic reviews.

[7]  Edwin Silverberg,et al.  Survival experience in the breast cancer detection demonstration project , 1987, CA: a cancer journal for clinicians.

[8]  S. Shapiro,et al.  Evidence on screening for breast cancer from a randomized trial , 1977, Cancer.

[9]  N. Wald,et al.  Report of the European Society for Mastology Breast Cancer Screening Evaluation Committee (1993) , 1993 .

[10]  A. Miller,et al.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[11]  R. Tarone,et al.  Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. , 1988, Journal of the National Cancer Institute.

[12]  S. Moss,et al.  A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer. , 1992, Journal of epidemiology and community health.

[13]  N. Day,et al.  Further evidence of benefits of a (non-randomised) breast cancer screening programme: the DOM project. , 1992, Journal of epidemiology and community health.

[14]  J. Austoker.  Cancer Prevention in Primary Care: Screening and self examination for breast cancer , 1994, BMJ.

[15]  L. Tabár,et al.  What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. , 1987, British Journal of Cancer.

[16]  S. Ciatto,et al.  Time interval since last test in a breast cancer screening programme: a case-control study in Italy. , 1989, Journal of epidemiology and community health.

[17]  S. Wall,et al.  Breast cancer screening with mammography: overview of Swedish randomised trials , 1993, The Lancet.

[18]  B. Muir,et al.  Oblique-view mammography: adequacy for screening. Work in progress. , 1984, Radiology.

[19]  J. Hendriks,et al.  MAMMOGRAPHIC SCREENING AND BREAST CANCER MORTALITY: AGE-SPECIFIC EFFECTS IN NIJMEGEN PROJECT, 1975-82 , 1985, The Lancet.

[20]  I Andersson,et al.  Number of projections in mammography: influence on detection of breast disease. , 1978, AJR. American journal of roentgenology.

[21]  L W Bassett,et al.  Breast cancer detection: one versus two views. , 1987, Radiology.

[22]  S. Fletcher,et al.  Does Screening for Breast Cancer Save Lives , 1990 .

[23]  E. Mason,et al.  Five‐year‐plus survival of breast screenees , 1981, Cancer.

[24]  A. Miller,et al.  Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986 , 1989 .

[25]  J. Hendriks,et al.  Screening for breast cancer in nijmegen. report of 6 screening rounds, 1975–1986 , 1989, International journal of cancer.

[26]  T. Landberg,et al.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. , 1988, BMJ.

[27]  M Moskowitz,et al.  Breast cancer: age-specific growth rates and screening strategies. , 1986, Radiology.

[28]  A. Richardson,et al.  The effectiveness of breast cancer screening by mammography in younger women. , 1993, The Online journal of current clinical trials.

[29]  E A Sickles,et al.  Deficiencies in the analysis of breast cancer screening data. , 1993, Journal of the National Cancer Institute.

[30]  J. Hendriks,et al.  One-view versus two-view mammography in baseline screening for breast cancer: a review. , 1992, The British journal of radiology.

[31]  S. Shapiro,et al.  Ten- to fourteen-year effect of screening on breast cancer mortality. , 1982, Journal of the National Cancer Institute.

[32]  L. Garfinkel,et al.  Insights into breast cancer screening of younger women. Evidence from the 14‐year follow‐up of the breast cancer detection demonstration project , 1993, Cancer.

[33]  L. Tabár,et al.  The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. , 1989, Journal of epidemiology and community health.

[34]  L. Tabár,et al.  Update of the Swedish two-county program of mammographic screening for breast cancer. , 1992, Radiologic clinics of North America.

[35]  A. Huggins,et al.  Edinburgh trial of screening for breast cancer: mortality at seven years , 1990, The Lancet.

[36]  Mammographic breast cancer screening--a randomized trial in Malmö, Sweden. , 1985, Maturitas.